# Study for Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma

> **NCT06334991** · PHASE1 · RECRUITING · sponsor: **ImmunityBio, Inc.** · enrollment: 10 (estimated)

## Conditions studied

- Non-Hodgkin Lymphoma Refractory/ Relapsed

## Interventions

- **BIOLOGICAL:** CD19 t-haNK

## Key facts

- **NCT ID:** NCT06334991
- **Lead sponsor:** ImmunityBio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-23
- **Primary completion:** 2028-03
- **Final completion:** 2028-03
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06334991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06334991, "Study for Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06334991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*